
Casualties of War: Milken Institute Review Second Quarter 2015

Who Gets What — and Why: The New Economics of Matchmaking and Market Design

PLENARY - Molecule to man (and woman): Speeding translation to human trials

PANEL - Tech transfer 2.0: Innovation in university commercialization

PANEL - Social Media Changing Research Norms

PANEL - Optimists only - Is life sciences still a good investment?

From Passengers to Co-Pilots: Patient Roles Expand
